Groesbeck Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $906K | Hold |
1,869
| – | – | 1.27% | 25 |
|
|
2024
Q4 | $753K | Buy |
1,869
+100
| +6% | +$40.3K | 0.98% | 33 |
|
|
2024
Q3 | $823K | Sell |
1,769
-25
| -1% | -$11.6K | 1.21% | 28 |
|
|
2024
Q2 | $841K | Buy |
1,794
+21
| +1% | +$9.84K | 1.16% | 31 |
|
|
2024
Q1 | $741K | Hold |
1,773
| – | – | 0.79% | 41 |
|
|
2023
Q4 | $721K | Buy |
1,773
+300
| +20% | +$122K | 1% | 34 |
|
|
2023
Q3 | $512K | Buy |
1,473
+240
| +19% | +$83.4K | 0.78% | 48 |
|
|
2023
Q2 | $434K | Hold |
1,233
| – | – | 0.66% | 51 |
|
|
2023
Q1 | $388K | Hold |
1,233
| – | – | 0.58% | 59 |
|
|
2022
Q4 | $356K | Buy |
1,233
+120
| +11% | +$34.6K | 0.6% | 57 |
|
|
2022
Q3 | $314K | Hold |
1,113
| – | – | 0.52% | 66 |
|
|
2022
Q2 | $314K | Hold |
1,113
| – | – | 0.52% | 66 |
|
|
2022
Q1 | $290K | Hold |
1,113
| – | – | 0.32% | 93 |
|
|
2021
Q4 | $244K | Hold |
1,113
| – | – | 0.31% | 84 |
|
|
2021
Q3 | $202K | Sell |
1,113
-50
| -4% | -$9.08K | 0.23% | 104 |
|
|
2021
Q2 | $234K | Sell |
1,163
-400
| -26% | -$80.5K | 0.3% | 85 |
|
|
2021
Q1 | $336K | Hold |
1,563
| – | – | 0.48% | 72 |
|
|
2020
Q4 | $369K | Hold |
1,563
| – | – | 0.6% | 61 |
|
|
2020
Q3 | $425K | Buy |
1,563
+13
| +0.8% | +$3.54K | 0.8% | 49 |
|
|
2020
Q2 | $450K | Buy |
+1,550
| New | +$450K | 0.89% | 48 |
|